Answers are grounded in this paper and cite their sources.
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss, characterized by the degeneration of the macula and impaired vision due to abnormalities in photoreceptors and the retinal pigment epithelium (RPE), often leading to neovascularization.Traditional herbal formulas, such as Jakyakgamcho-tang (JGT), have been proposed as potential therapeutic agents for retinal diseases. This study aimed to investigate the protective effect of JGT in human retinal cells and zebrafish model of retinal degeneration. JGT consists of two medicinal herbs, Paeoniae Radix and Glycyrrhizae Radix. The study focused on the ability of JGT to inhibit the formation of advanced glycation end-products (AGEs) and block the receptor for AGEs (RAGE) binding. The protective effects of JGT were assessed using human retinal endothelial cells (HRECs), human retinal pigment epithelial cells (ARPE-19), and N-methyl-N-nitrosourea (MNU)-exposed zebrafish. JGT exhibited significant inhibitory effects on AGE formation and RAGE binding. It also reduced the changes in cell membrane permeability in ARPE-19 cells treated with methylglyoxal (MG). When applied to HRECs stimulated with vascular endothelial growth factor (VEGF), a potent angiogenesis inducer, JGT inhibited VEGF-induced tube formation and cell migration. Additionally, JGT and its key components -albiflorin, isoliquiritin, and paeoniflorin -helped restore the thickness of the outer nuclear layer (ONL) in MNU-treated zebrafish. These findings suggest that JGT has therapeutic potential to treat retinal degenerative diseases, such as AMD. JGT can inhibit AGE formation, modulate angiogenesis, and protect retinal cells, which supports its potential as a novel therapeutic option to prevent retinal dysfunction and degeneration.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: